APCCC 2019 PRESENTATION SLIDES

Get Free Access to Session Slides

APCCC 2019 VL

APCCC 2019 Welcome Address - Silke Gillessen and Aurelius Omlin

Details
Advanced Prostate Consensus Conference (APCCC 2019) welcome address with Silke Gillessen, MD and Aurelius Omlin, MD Biographies: Presented by: Silke Gillessen, MD, senior consultant in the Medical Oncology-Hematology Department at the Kantonsspital St. Gallen, St Gallen, Switzerland and Co-founder of the Advanced Prostate Cancer Consensus Conference (APCCC), previously of the University of Manches...

Clinical Utility of Molecular Biomarkers Presentation - Johann de Bono

Details
Professor de Bono presents the clinical utility of predictive molecular biomarkers in advanced prostate cancer during the first session of the Advanced Prostate Cancer Consensus Conference (APCCC 2019). Biographies: Johann de Bono, MB ChB FRCP MSc Ph.D. FMedSci. Professor Johann de Bono is Regius Professor of Cancer Research and a Professor in Experimental Cancer Medicine at The Institute of Cance...

The Side Effects of Advanced Prostate Cancer Consensus Conference 2019 (APCCC) - Silke Gillessen and Aurelius Omlin

Details
In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options that require careful decision-making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that also are costly and potentially toxic. Further developments in novel next-generation imaging methods, biomarkers, mo...

Looking Forward to the APCCC 2019 - Brenda Martone

Details
Alicia Morgans and Brenda Martone discuss the upcoming Advanced Prostate Cancer Consensus Conference (APCCC 2019). This global conference focuses on the grey areas where Level 1 Evidence is not available to guide treatment decisions in the clinic. Experts from around the globe will gather in Basel Switzerland from August 28 - August 31 to discuss areas of controversy in the treatment of prostate c...

Preview of the Advanced Prostate Cancer Consensus Conference 2019 (APCCC) - Silke Gillessen and Aurelius Omlin

Details
Silke Gillessen, MD and Aurelius Omlin, MD discuss the inception of the biennial Advanced Prostate Cancer Consensus Conference (APCCC) which will be held in Basel this August. The intent of the meeting is to drive international consensus on key areas of prostate cancer practice where there are no clear guidelines or level 1 evidence. 75% of the panelists must agree on each topic to reach a consens...

Preview of the APCCC 2019 - Interview with Silke Gillessen

Details
Silke Gillessen, in conversation with Alicia Morgans provides an overview of many of the changes taking place in prostate cancer clinical practice since the 2017 APCCC. They touch upon the new data that is driving change in clinical practice and some unanswered questions that have arisen and will be discussed in the upcoming 2019 Advanced Prostate Cancer Consensus Conference (APCCC 2019). The next...

APCCC 2017: Roundtable Discussion Neal Shore, Fred Saad & Charles Ryan

Details
(Length of Discussion: 60 min) Neal Shore, MD, Fred Saad, MD and Charles Ryan, MD discuss the outcomes from the 2015 APCCC conference including level one evidence, trying to understand treating advanced prostate cancer patients on diagnostic markers, imaging, systemic therapies, as well as interventional surgical and radiation treatments. They discuss some of the key discussion points and lectures...